Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Pract Radiat Oncol. 2012 Mar 12;3(1):2–8. doi: 10.1016/j.prro.2012.01.006

Table 2.

Patients treated with brachytherapy

Characteristic (n=93) Patients Number (%)
Age at start of RT
 Median (66 years)
 Range (49–83 years)
Stratum
 Academic 23 (24.7)
 Non-academic 70 (75.3)
Risk groupa
 Low (favorable) 61 (66.3)
 Intermediate 23 (25.0)
 High (unfavorable) 8 (8.7)
Type of implant
 Iodine-125 72 (77.4)
 Palladium-103 14 (15.1)
 High dose rate 7 (7.5)
Endocrine manipulation
 No 76 (81.7)
 Yes 17 (18.3)
a

Excluding 1 patient for whom risk group could not be determined.